solli

This article is part ofsolli’sJuly series exploringThe State of the Agency. I spent more than a decade in media agencies working with pharma companies, locally and globally, and one tension was always there: Procurement and brand marketing were often looking at the same agency relationship from completely different angles. Agencies have played their part in creating the pressure. During RFPs, they price aggressively to win, but once the celebrations are over, the account still has to make money.

After unveiling its artificial intelligence-powered operating system for health and pharma marketing this past spring, Doceree officially launched the Daily Command platform Tuesday. The platform was designed and tested by a group of 75 senior leaders representing major pharmas and agencies, then beta tested by a smaller group of partners including Deerfield and Avalere Health. It’s now available to U.S. drugmakers, agencies and publishers.

A new ecosystem of tech tools from Real Chemistry is aimed at offering health and pharma marketers artificial intelligence support throughout the entire commercialization process.

In this Partner Interview sponsored by Doceree, Rich Springham speaks with Harshit Jain, Founder and Global CEO of Doceree, and Ryan Mason, Chief Strategy Officer at Avalere Health, about the collaborative journey behind Daily Command. Together, they explore how involving healthcare marketers, agencies, and industry partners throughout product development has helped create an AI-powered platform designed to address real-world challenges.

A proposed rule change from the U.S. Department of Health and Human Services appears to represent the next step in the federal government’s September 2025 vow to rein in direct-to-consumer prescription drug advertising. The proposal was included in HHS’ regulatory agenda for the rest of 2026, released earlier this month.

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Hot on the heels of a new Diaceutics report on data-driven strategies for improving healthcare professional targeting in rare disease campaigns, the company is lending its expertise to a collaboration similarly focused on boosting HCP outreach. Lab data from Diaceutics has been integrated into HealthLink Dimensions’ HealthLink Profile, the duo announced Thursday, adding real-world diagnostic testing data to the HCP dataset and activation platform.

A new software tool born out of a collaboration between PurePlay AI and PurpleLab is designed to unlock a mid-funnel view of audience metrics—homing in on a potentially valuable midpoint between audience quality and script lift. The Embedded Pulse solution is built on PurpleLab’s identity resolution technology to provide same-day, impression-level patient and HCP data that’s verified and de-identified and tied to HCP visits.

This article is part of solli’s July series exploring The State of the Agency. In the span of just a few years, what was once a moderate stream of developments in artificial intelligence technology has accelerated into a veritable deluge, shaking up and completely overhauling entire industries in the process—and pharma media has been far from immune.

Doceree’s latest offering is aimed at standardizing campaign measurement across the channels commonly used to reach healthcare professionals. The closed-loop measurement framework builds on Doceree’s existing measurement capabilities and also serves as the foundation of the company’s soon-to-launch Daily Command platform. The technology encompasses nine HCP channels: point of care, programmatic, account-based marketing, copay, CTV, DOOH, social, email and text.